Fluzalp Quadrivalent

FLUZALP Quadrivalent is a vaccine manufactured by Anzalp Pharmasolutions Pvt and helps protect against influenza illness (flu).. Ltd.. It is a vaccine meant for the age group of 4 years and above. The quadruple strain formula provides protection for up to 6 months*.  The product’s dosage form is injection, suspension and is administered via intramuscular form.

Labeller Name: Anzalp Pharmasolutions Pvt. Ltd.

Dosage Form:  Suspension for Injection – A liquid preparation, suitable for injection, which consists of solid particles dispersed throughout a liquid phase in which the particles are not soluble. It can also consist of an oil phase dispersed throughout an aqueous phase, or vice-versa.

• Influenza A Virus A/Nebraska/14/2019 (H1n1) Antigen (Mdck Cell Derived, Propiolactone Inactivated) 15 Ug/.5ml
• Influenza A Virus A/Delaware/39/2019 (H3n2) Antigen (Mdck Cell Derived, Propiolactone Inactivated) 15 Ug/.5ml
• Influenza B Virus B/Singapore/Inftt-16-0610/2016 Antigen (Mdck Cell Derived, Propiolactone Inactivated) 15 Ug/.5ml
• Influenza B Virus B/Darwin/7/2019 Antigen (Mdck Cell Derived, Propiolactone Inactivated) 15 Ug/.5ml